Multiple Sclerosis

KCEP 210: Multiple Sclerosis Study Guide

Overview of Multiple Sclerosis (MS)

  • Definition: Multiple Sclerosis (MS) is a chronic, progressive disease of the central nervous system (CNS), which includes the brain and spinal cord.

  • Systems Involved: Primarily affects the neurological and immune systems.

  • Incidence: Most commonly strikes individuals aged 20-40 years.

  • Curability: Currently, MS is not curable, but medications can help manage the disease.

Characteristics of MS

  • Multiple: Refers to the many scattered areas of damage in the brain and spinal cord.

  • Sclerosis: Refers to the hardened tissue in the affected areas due to damage.

  • Mechanism: The immune system attacks the myelin sheath (protective covering of nerve fibers), leading to communication problems between the brain and body.

  • Medication Impact: Medications can help by speeding recovery from attacks and modifying the course of the disease along with its symptoms.

Symptoms and Impact

  • Lesions: Damaged myelin leads to lesions that can cause symptoms such as numbness, pain, or tingling below the lesion.

  • Example of Symptoms: Symptoms experienced can include issues such as numbness, lack of coordination, and changes in sensory perception, influenced by lesion locations (e.g., optic nerve, brain stem, motor nerve tract).

  • Physical Activity: Some individuals with MS can still engage in athletic activities; however, factors such as body temperature can drastically affect sensory perception and physical performance.

Epidemiological Data

  • Prevalence in Canada: Approximately 90,000 Canadians have MS, which corresponds to about 250 people per 100,000.

  • Cost of Treatment: The annual cost of medications is around $12,000 per patient, contributing to a total of 1.5 to 2 billion dollars in medical expenses annually.

  • Survival Rates: In 1936, only 8% survived beyond 20 years; now, patients can expect to live within a few years of average life expectancy minus 7 years.

Causes of MS

  • Understanding MS: While the exact causes remain largely unknown, MS is classified as an autoimmune disease, where the body's immune system mistakenly attacks its own tissues.

  • T-cells and Monocytes: These cells are involved in the destruction of the myelin sheath.

Risk Factors

  • Demographics:

    • Age: Most often occurs in individuals aged 20-40.

    • Sex: Women are approximately twice as likely to develop MS compared to men.

    • Family History: A family history of MS increases susceptibility.

  • Environmental Factors:

    • Certain viruses, particularly Epstein-Barr, have been linked.

    • Geographic location, particularly temperate climates, shows higher incidences (e.g., Canada, northern US).

  • Autoimmune Diseases: Presence of other autoimmune conditions (like thyroid disease or type 1 diabetes) may raise risk.

  • Lifestyle Factors: Smoking is a contributing factor, and race also influences risk, being highest in individuals of Northern European descent.

Symptoms of MS

  • Significant Symptoms: 78% of patients experience fatigue. Other symptoms include:

    • Visual disturbances (due to optic nerve lesions)

    • Balance and coordination issues (from cerebellum lesions)

    • Muscle weakness and paralysis (from motor nerve tract lesions)

    • Altered sensations and pain (from sensory nerve tract lesions)

  • Symptoms vary widely depending on individual experiences and lesion locations.

Course of the Disease

  • Exacerbations and Remissions: MS is characterized by episodes of exacerbation (flare-ups) where symptoms worsen, contrasted by periods of remission where symptoms stabilize.

  • Types of MS:

    1. Relapsing-Remitting MS (RRMS): Most common type; characterized by clear relapses followed by periods of remission.

    2. Secondary Progressive MS (SPMS): Follows RRMS where distinct relapses become less notable and disability gradually advances.

    3. Primary Progressive MS (PPMS): Steady progression of disability without discrete relapses.

    4. Progressive-Relapsing MS (PRMS): Characterized by progressive disease from the onset with relapses but no periods of stability.

Exercise and MS

  • Physical Activity Guidelines: For adults with mild to moderate MS:

    • Engage in at least 30 minutes of moderate-intensity aerobic activity twice a week.

    • Incorporate strength training exercises for major muscle groups, also twice a week.

  • Benefits of Exercise: Exercise is shown to improve aerobic capacity, muscle strength, and overall quality of life.

  • Risks and Considerations: MS may affect fitness levels, lead to fatigue, and individuals may have heat intolerance; however, exercise is manageable and does not trigger exacerbations when properly guided.

  • Psychological Considerations: Individuals might also experience symptoms of depression, which can be mitigated through proper exercise regimes.

  • Recommendations: Activities should increase gradually in intensity and frequency and monitoring of perceived exertion is important.